Evidence map›Paper›PMID 1985103›Full record

ArticleThe Journal of clinical investigation1991

Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels.

B A Wolf, J R Williamson, R A Easom, K Chang, W R Sherman, J Turk

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 186 citations in OpenAlex.

  1. Trial
  2. Acute Hyperglycemia-Induced Injury in Myocardial Infarction.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Update on the management of diabetic polyneuropathies.Diabetes, metabolic syndrome and obesity : targets and therapy · 2011
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

B A WolfDepartment of Pathology, Washington University School of Medicine, Saint Louis, Missouri 63110.
J R Williamson
R A Easom
K Chang
W R Sherman
J Turk
Washington University in St. Louis · US

Funding

PHOSPHOLIPID-DERIVED MEDIATORS AND INSULIN SECRETIONK04DK001553 · NIDDK · WASHINGTON UNIVERSITY · PI TURK, JOHN W · 1987 to 1991
–
PHOSPHOLIPID-DERIVED MEDIATORS AND INSULIN SECRETIONR01DK034388 · NIDDK · WASHINGTON UNIVERSITY · PI TURK, JOHN W · 1987 to 1992
–
ROLE OF HORMONES AND POLYOLS IN DIABETIC EYE DISEASER01EY006600 · NEI · WASHINGTON UNIVERSITY · PI WILLIAMSON, JOSEPH R · 1986 to 1996
–
NEI NIH HHS EY 06600NIDDK NIH HHS KO4 DK 01553NIDDK NIH HHS R01 DK 34388
6 · The paper itself

Abstract

The present experiments were undertaken to examine the hypothesis that glucose-induced increased de novo synthesis of 1,2-diacyl-sn-glycerol (which has been observed in a number of different tissues, including retinal capillary endothelial cells exposed to elevated glucose levels in vitro) and associated activation of protein kinase C may play a role in mediating glucose-induced vascular functional changes. We report here that twice daily instillation of 30 mM glucose over 10 d in a rat skin chamber granulation tissue model induces approximately a 2.7-fold increase in diacylglycerol (DAG) levels (versus tissues exposed to 5 mM glucose) in association with marked increases in vascular clearance of albumin and blood flow. The glucose-induced increase in DAG levels as well as the vascular functional changes are prevented by addition of 3 mM pyruvate. Pharmacological activation of protein kinase C with the phorbol ester TPA in the presence of 5 mM glucose increases microvascular albumin clearance and blood flow, and similar effects are observed with 1-monoolein (MOG), a pharmacological inhibitor of the catabolism of endogenous DAG. A pharmacological inhibitor of protein kinase C (staurosporine) greatly attenuates the rise in microvascular albumin clearance (but not the rise in blood flow) induced by glucose or by MOG. These findings are compatible with the hypothesis that elevated concentrations of glucose increase tissue DAG content via de novo synthesis, resulting in protein kinase C activation, and that these biochemical events are among the factors that generate the increased microvascular albumin clearance.

Indexed as

AlkaloidsAnimalsCapillary PermeabilityDiabetic AngiopathiesDiglyceridesGlucoseGlyceridesGranulation TissueMaleMicrocirculationNADProtein Kinase CRatsRats, Inbred StrainsStaurosporineTetradecanoylphorbol AcetateAlkaloidsDiglyceridesGlucoseGlyceridesmonooleinNADProtein Kinase CStaurosporineTetradecanoylphorbol Acetate

Identifiers

PMID1985103
PMCPMC294984
OpenAlexW2093739412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.